Equities

Novo Integrated Sciences Inc

NVOS:NAQ

Novo Integrated Sciences Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.309
  • Today's Change-0.019 / -5.79%
  • Shares traded218.84k
  • 1 Year change-88.45%
  • Beta-0.6912
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

  • Revenue in USD (TTM)13.52m
  • Net income in USD-24.33m
  • Incorporated2008
  • Employees127.00
  • Location
    Novo Integrated Sciences Inc11120 NE 2ND STREET, SUITE 100BELLEVUE 98004United StatesUSA
  • Phone+1 (206) 617-9797
  • Fax+1 (386) 943-6232
  • Websitehttps://www.novointegrated.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Modern Mobility Aids Inc0.00-1.59m4.58m-----------0.0177-0.01770.00-0.0040.00-------4,668.68---------------------------371.94------
Syra Health Corp7.07m-4.19m4.69m78.00--1.51--0.6631-0.6709-0.67091.190.31692.81--11.2790,635.38-166.37---287.17--23.56---59.23-----177.320.0518---1.83---38.72------
CompuMed Inc1.78m-151.00k4.87m8.00--37.44--2.74-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
Selectis Health Inc37.33m-6.17m4.91m574.00------0.1315-2.02-2.0212.19-1.050.8922--15.6765,027.49-14.67-3.03-25.30-3.58-----16.44-4.84---2.981.11---9.4058.97-64.93---47.72--
Biocorrx Inc36.76k-4.29m5.45m5.00------148.13-0.4837-0.48370.0042-1.120.0595--0.3422---697.45-291.68----49.4067.13-11,718.77-3,208.40---2.96-----58.31-25.0413.79------
Inspire Veterinary Partners Inc17.13m-19.33m5.96m156.00------0.3478-134.72-134.724.54-0.6310.816521.61246.52109,778.20-89.79---190.96--19.47---109.98--0.1311-2.741.20--69.56---206.68------
Ethema Health Corp5.27m943.69k6.18m65.003.64--6.071.170.00020.00020.0014-0.00220.6511--14.1781,064.167.10-37.68--------10.91-94.87---1.777.30--10.8765.34652.41--74.97--
Novo Integrated Sciences Inc13.52m-24.33m6.25m127.00--0.6277--0.4624-1.38-1.380.79550.52250.38048.217.55106,432.80-68.51-29.43-113.88-35.6437.6839.59-180.11-110.250.2227-0.66790.2093--7.117.1759.77---22.73--
NewGenIvf Group Ltd0.00-690.85k6.41m----0.1508-----0.1999-0.19990.004.190.00-------1.50---1.54--------------0.0944-------237.99------
Interpace Biosciences Inc41.68m3.00m7.13m108.002.41--2.080.1710.6740.63029.46-2.852.8814.197.10385,888.9020.72-38.19---69.7359.0149.447.19-41.010.46954.95----26.3112.93118.96--0.9184--
Kindly MD Inc3.10m-2.44m7.57m23.00--1.73--2.44-0.4652-0.46520.57430.73760.98675.94471.36134,643.90-77.81---99.26--93.94---78.86--5.36-5.610.0517---0.488--36.34------
Mangoceuticals Inc866.79k-9.13m7.61m----0.5364--8.78-0.4388-0.43880.0410.47470.093519.32-----98.48---107.62--58.19---1,052.90--0.3653-38.860.0134--8,082.22---361.07------
Caremax Inc784.55m-782.86m8.58m1.45k------0.0109-208.41-208.41208.34-38.730.9776--6.10541,069.60-97.55---160.21---3.31---99.78-----1.951.57--19.01---1,707.99------
US NeuroSurgical Holdings Inc0.00-1.02m8.77m2.00--4.39-----0.0928-0.09280.000.14820.00----0.00-45.80-14.62-66.91-19.89-------36.77----0.00------38.97------
Data as of Sep 20 2024. Currency figures normalised to Novo Integrated Sciences Inc's reporting currency: US Dollar USD

Institutional shareholders

5.66%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 2024344.34k1.81%
BlackRock Fund Advisorsas of 30 Jun 2024290.45k1.52%
Geode Capital Management LLCas of 30 Jun 2024155.45k0.82%
Jane Street Capital LLCas of 30 Jun 202492.99k0.49%
Virtu Americas LLCas of 30 Jun 202476.45k0.40%
SSgA Funds Management, Inc.as of 30 Jun 202433.28k0.18%
UBS Securities LLCas of 30 Jun 202431.06k0.16%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 202427.91k0.15%
XTX Markets LLCas of 30 Jun 202414.51k0.08%
Millennium Management LLCas of 30 Jun 202411.51k0.06%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.